Nanjing, China

Fengying Guo


 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Fengying Guo in Pharmaceutical Research

Introduction

Fengying Guo is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of caspase inhibitors. With a total of 2 patents, his work has the potential to impact the treatment of various diseases.

Latest Patents

Fengying Guo's latest patents include innovative compounds that serve as caspase inhibitors. The first patent describes a bicyclic compound represented by a specific formula, which is a pharmaceutically acceptable salt or tautomer. This compound is recognized for its application as a caspase inhibitor. The second patent discloses a class of compounds that also function as caspase inhibitors, emphasizing their use in treating caspase-related diseases.

Career Highlights

Throughout his career, Fengying Guo has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Medshine Discovery Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Fengying Guo has collaborated with several professionals in his field, including Haiying He and Songliang Wu. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Fengying Guo's contributions to pharmaceutical research, particularly in the area of caspase inhibitors, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…